Top Markets
#1 Verus Coin Verus Coin +45.28%
#2 Status Status +19.17%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#4 GoPlus Security GoPlus Security +16.92%
#5 Wrapped NXM Wrapped NXM +15.51%
#6 Ontology Gas Ontology Gas +11.14%
#7 DMT-NAT DMT-NAT +9.14%
#8 BankrCoin BankrCoin +8.23%
#9 Pons Pons +7.43%
#10 Nesa Nesa +7.39%
Coin of the day
Verus Coin Verus Coin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Pozycja w akcjach #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Cena akcji
$1.83
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$6.53M
Zmiana (1 dzień)
-1.61%
Zmiana (1 rok)
-85.57%
Kraj
US
Handel Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Kategoria

Healthcare
Historia ceny akcji dla Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Najwyższa cena zamknięcia: $1.89 dnia 2026-08-01

Najniższa cena zamknięcia: $46.78 dnia 2023-01-01
Historia cen akcji firmy Cadrenal Therapeutics, Inc. Common Stock od 2023 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE